Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 11, 2015, Pages 14214-14220

  Lei, Xuhui ^a   Chang, Liang ^b   Ye, Wei ^a   Jiang, Chuanlu ^a   Zhang, Zhiren ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; HMGA2; Invasion; Migration; Raf kinase inhibitor protein (RKIP)

Indexed keywords

GELATINASE B; HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; MMP3 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PEBP1 PROTEIN, HUMAN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; STROMELYSIN;

BRAIN TUMOR; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; GLIOMA; HUMAN; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HMGA2 PROTEIN; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 85013269757     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abrams DA, Hanson JA, Brown JM, Hsu FP, Delashaw JB Jr and Bota DA. Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma. J Clin Neurosci 2015; 22: 35-39.
2. Afshordel S, Kern B, Clasohm J, Konig H, Priester M, Weissenberger J, Kogel D and Eckert GP. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation-impact of Ras-/Rho-prenylation. Pharmacol Res 2015; 91: 69-77.
3. Ahmed R, Oborski MJ, Hwang M, Lieberman FS and Mountz JM. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res 2014; 6: 149-170.
4. Yang L, Gao S, Asghar S, Liu G, Song J, Wang X, Ping Q, Zhang C and Xiao Y. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int J Biol Macromol 2015; 72: 1391-1401.
5. Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC and Keller ET. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer. Prostate 2015; 75: 292-302.
6. Al-Mulla F, Bitar MS, Taqi Z and Yeung KC. RKIP: much more than Raf kinase inhibitory protein. J Cell Physiol 2013; 228: 1688-1702.
7. Zuo H, Lin T, Wang D, Peng R, Wang S, Gao Y, Xu X, Zhao L and Su Z. RKIP Regulates Neural Cell Apoptosis Induced by Exposure to Microwave Radiation Partly Through the MEK/ERK/CREB Pathway. Mol Neurobiol 2015; 51: 1520-9.
8. Zhang XM, Zhou C, Gu H, Yan L and Zhang GY. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. Int J Clin Exp Pathol 2014; 7: 5902-5908.
9. Yousuf S, Duan M, Moen EL, Cross-Knorr S, Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E and Chatterjee D. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS One 2014; 9: e92478.
10. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z and Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003; 95: 878-889.
11. Ramaswamy P, Aditi Devi N, Hurmath Fathima K and Dalavaikodihalli Nanjaiah N. Activation of NMDA receptor of glutamate influences MMP-2 activity and proliferation of glioma cells. Neurol Sci 2014; 35: 823-829.
12. Chen Z, Cheng Q, Ma Z, Xi H, Peng R and Jiang B. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98. Biomed Res Int 2013; 2013: 695179.
13. Yesilkanal AE and Rosner MR. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer. Crit Rev Oncog 2014; 19: 447-454.
14. Wu Z, Fu C, Shi L, Ruan L, Lin D and Guo C. Structural basis for RKIP binding with its substrate Raf1 kinase. Biotechnol Lett 2014; 36: 1869-1874.
15. Sun M, Gomes S, Chen P, Frankenberger CA, Sankarasharma D, Chung CH, Chada KK and Rosner MR. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. Oncogene 2014; 33: 3528-3537.
16. Tian Y, Hao S, Ye M, Zhang A, Nan Y, Wang G, Jia Z, Yu K, Guo L, Pu P, Huang Q and Zhong Y. MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly. Biochem Biophys Res Commun 2015; 458: 307-312.
17. He X, Huang Q, Qiu X, Liu X, Sun G, Guo J, Ding Z, Yang L, Ban N, Tao T and Wang D. LAP3 promotes glioma progression by regulating proliferation, migration and invasion of glioma cells. Int J Biol Macromol 2015; 72: 1081-1089.
18. Leng TD, Li MH, Shen JF, Liu ML, Li XB, Sun HW, Branigan D, Zeng Z, Si HF, Li J, Chen J and Xiong ZG. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells. CNS Neurosci Ther 2015; 21: 252-261.
19. Fan YC, Zhu YS, Mei PJ, Sun SG, Zhang H, Chen HF, Chen C and Miao FA. Cullin1 regulates proliferation, migration and invasion of glioma cells. Med Oncol 2014; 31: 227.
20. Mao J, Zhang M, Zhong M, Zhang Y and Lv K. MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion. Mol Cell Biochem 2014; 396: 117-128.
21. Zhou X, Zhan W, Bian W, Hua L, Shi Q, Xie S, Yang D, Li Y, Zhang X, Liu G and Yu R. GOLPH3 regulates the migration and invasion of glioma cells though RhoA. Biochem Biophys Res Commun 2013; 433: 338-344.
22. Huasong G, Zongmei D, Jianfeng H, Xiaojun Q, Jun G, Sun G, Donglin W and Jianhong Z. Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells. Brain Res 2015; 1600: 59-69.
23. Bonavida B. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-kappaB/Snail/YY1/RKIP resistance-driver loop. Crit Rev Oncog 2014; 19: 431-445.
24. Liu H, Li P, Li B, Sun P, Zhang J, Wang B and Jia B. RKIP promotes cisplatin-induced gastric cancer cell death through NF-kappaB/Snail pathway. Tumour Biol 2015; 36: 1445-1453.
25. Wu K and Bonavida B. The activated NFkappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 2009; 29: 241-254.
26. Xinzhou H, Ning Y, Ou W, Xiaodan L, Fumin Y, Huitu L and Wei Z. RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix. Mol Biol (Mosk) 2011; 45: 1004-1011.
27. Cheng X, Lu SH and Cui Y. ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration. Cancer Lett 2010; 290: 87-95.
28. Watanabe A, Hoshino D, Koshikawa N, Seiki M, Suzuki T and Ichikawa K. Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia. PLoS Comput Biol 2013; 9: e1003086.
29. Reeves CV, Wang X, Charles-Horvath PC, Vink JY, Borisenko VY, Young JA and Kitajewski JK. Anthrax toxin receptor 2 functions in ECM homeostasis of the murine reproductive tract and promotes MMP activity. PLoS One 2012; 7: e34862.
30. Hoshino D, Koshikawa N, Suzuki T, Quaranta V, Weaver AM, Seiki M and Ichikawa K. Establishment and validation of computational model for MT1-MMP dependent ECM degradation and intervention strategies. PLoS Comput Biol 2012; 8: e1002479.
31. Galvez BG, Matias-Roman S, Yanez-Mo M, Sanchez-Madrid F and Arroyo AG. ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 2002; 159: 509-521.
32. Sheen YS, Liao YH, Lin MH, Chu CY, Ho BY, Hsieh MC, Chen PC, Cha ST, Jeng YM, Chang CC, Chiu HC, Jee SH and Kuo ML. IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma. J Invest Dermatol 2015; 135: 1065-1073.
33. Liu H, Li P, Li B, Sun P, Zhang J, Wang B and Jia B. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA-2 and OPN. Tumour Biol 2014; 35: 11949-11958.
34. Mu G, Liu H, Zhou F, Xu X, Jiang H, Wang Y and Qu Y. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas. Hum Pathol 2010; 41: 493-502.